Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: A Phase 1b Study of ACP-196 in Combination With Obinutuzumab for Patients With Relapsed / Refractory or Untreated CLL/SLL/PLL
Brief Summary: To evaluate the safety and preliminary efficacy of acalabrutinib in combination with obinutuzumab in 2 separate cohorts of patients.